Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum]

Tagami M, Sai R, Fukuda M, Azumi A. Clin Ophthalmol. 2017;11:403–408.Page 405, Comparison of injection intervals section, line 6, “We also compared the intervals between the last and the second-to the-last intravitreal injection of ranibizumab and first and the second intravitrea...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tagami M, Sai R, Fukuda M, Azumi A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/c66e91a37ec1434d8ee5c186f28e8aea
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c66e91a37ec1434d8ee5c186f28e8aea
record_format	dspace
spelling	oai:doaj.org-article:c66e91a37ec1434d8ee5c186f28e8aea2021-12-02T01:37:31ZProlongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum]1177-5483https://doaj.org/article/c66e91a37ec1434d8ee5c186f28e8aea2017-04-01T00:00:00Zhttps://www.dovepress.com/corrigendum-prolongation-of-injection-interval-after-switching-t-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Tagami M, Sai R, Fukuda M, Azumi A. Clin Ophthalmol. 2017;11:403–408.Page 405, Comparison of injection intervals section, line 6, “We also compared the intervals between the last and the second-to the-last intravitreal injection of ranibizumab and first and the second intravitreal injection of aflibercept” should have read “We also compared the interval between the last injection of ranibizumab and the first injection of aflibercept with the interval between the first and the second injection of aflibercept”.Read the original article Tagami MSai RFukuda MAzumi ADove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 619-620 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Tagami M Sai R Fukuda M Azumi A Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum]
description	Tagami M, Sai R, Fukuda M, Azumi A. Clin Ophthalmol. 2017;11:403–408.Page 405, Comparison of injection intervals section, line 6, “We also compared the intervals between the last and the second-to the-last intravitreal injection of ranibizumab and first and the second intravitreal injection of aflibercept” should have read “We also compared the interval between the last injection of ranibizumab and the first injection of aflibercept with the interval between the first and the second injection of aflibercept”.Read the original article
format	article
author	Tagami M Sai R Fukuda M Azumi A
author_facet	Tagami M Sai R Fukuda M Azumi A
author_sort	Tagami M
title	Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum]
title_short	Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum]
title_full	Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum]
title_fullStr	Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum]
title_full_unstemmed	Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum]
title_sort	prolongation of injection interval after switching therapy from ranibizumab to aflibercept in japanese patients with macular edema secondary to branch retinal vein occlusion [corrigendum]
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/c66e91a37ec1434d8ee5c186f28e8aea
work_keys_str_mv	AT tagamim prolongationofinjectionintervalafterswitchingtherapyfromranibizumabtoafliberceptinjapanesepatientswithmacularedemasecondarytobranchretinalveinocclusioncorrigendum AT sair prolongationofinjectionintervalafterswitchingtherapyfromranibizumabtoafliberceptinjapanesepatientswithmacularedemasecondarytobranchretinalveinocclusioncorrigendum AT fukudam prolongationofinjectionintervalafterswitchingtherapyfromranibizumabtoafliberceptinjapanesepatientswithmacularedemasecondarytobranchretinalveinocclusioncorrigendum AT azumia prolongationofinjectionintervalafterswitchingtherapyfromranibizumabtoafliberceptinjapanesepatientswithmacularedemasecondarytobranchretinalveinocclusioncorrigendum
_version_	1718402983789592576

Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum]

Ejemplares similares